Investments and Derivative Instruments | 3 Months Ended |
Mar. 31, 2014 |
Investments and Derivative Instruments [Abstract] | ' |
Investments and Derivative Instruments | ' |
Investments and Derivative Instruments |
Net Realized Capital Gains (Losses) |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | | | | | | | | | | | | | | | | | | | | |
(Before-tax) | 2014 | 2013 | | | | | | | | | | | | | | | | | | | | | | | | | |
Gross gains on sales [1] | $ | 108 | | $ | 1,613 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Gross losses on sales | (104 | ) | (54 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Net OTTI losses recognized in earnings | (7 | ) | (13 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Valuation allowances on mortgage loans | — | | 1 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Japanese fixed annuity contract hedges, net [2] | (9 | ) | 3 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Periodic net coupon settlements on credit derivatives/Japan | 5 | | (3 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Results of variable annuity hedge program | | | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. GMWB derivatives, net | 15 | | 47 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
U.S. macro hedge program | (10 | ) | (85 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Total U.S. program | 5 | | (38 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
International Program [3] | (23 | ) | (83 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Total results of variable annuity hedge program | (18 | ) | (121 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
GMIB/GMAB/GMWB reinsurance | 51 | | 337 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Coinsurance and modified coinsurance reinsurance contracts | (130 | ) | (399 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Other, net [4] | (2 | ) | 79 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Net realized capital gains (losses), before-tax | $ | (106 | ) | $ | 1,443 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Includes $1.5 billion of gross gains relating to the sales of the Retirement Plans and Individual Life businesses for the three months ended March 31, 2013. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | Includes for the three months ended March 31, 2014 and 2013, transactional foreign currency re-valuation related to the Japan fixed annuity product of $(30) and $151, respectively, as well as the change in value related to the derivative hedging instruments and the Japan government FVO securities of $21 and $(148), respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[3] | Includes $3 and $(33) of transactional foreign currency re-valuation for the three months ended March 31, 2014 and 2013, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[4] | For the three months ended March 31, 2014 and 2013, other, net gains and losses includes $(3) and $22, respectively, of transactional foreign currency re-valuation associated with the internal reinsurance of the Japan GMIB variable annuity business, which is offset in AOCI. Also includes for the three months ended March 31, 2014 and 2013, $(28) and $116, respectively, of other transactional foreign currency revaluation, primarily associated with the internal reinsurance of the Japan 3 wins variable annuity business, of which a portion is offset within realized gains and losses by the change in value of the associated hedging derivatives. Includes $71 of gains relating to the sales of the Retirement Plans and Individual Life businesses for the three months ended March 31, 2013. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Net realized capital gains and losses from investment sales, are reported as a component of revenues and are determined on a specific identification basis. Before tax, net gains and losses on sales and impairments previously reported as unrealized gains in AOCI were $3 and $1.5 for the three months ended March 31, 2014 and 2013, respectively. Proceeds from sales of AFS securities totaled $3.5 billion and $4.8 billion, for the three months ended March 31, 2014 and 2013, respectively. |
Other-Than-Temporary Impairment Losses |
The following table presents a roll-forward of the Company’s cumulative credit impairments on debt securities held. |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | | | | | | | | | | | | | | | | | | | | |
(Before-tax) | 2014 | 2013 | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance, beginning of period | $ | (410 | ) | $ | (813 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Additions for credit impairments recognized on [1]: | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Securities not previously impaired | (3 | ) | (5 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Securities previously impaired | (3 | ) | — | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Reductions for credit impairments previously recognized on: | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Securities that matured or were sold during the period | 30 | | 111 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Securities due to an increase in expected cash flows | 4 | | 1 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance, end of period | $ | (382 | ) | $ | (706 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Available-for-Sale Securities |
The following table presents the Company’s AFS securities by type. |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | December 31, 2013 |
| Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit OTTI [1] | | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit OTTI [1] |
ABS | $ | 1,060 | | $ | 15 | | $ | (43 | ) | $ | 1,032 | | $ | (2 | ) | | $ | 1,172 | | $ | 13 | | $ | (56 | ) | $ | 1,129 | | $ | (2 | ) |
|
CDOs [2] | 1,216 | | 93 | | (33 | ) | 1,275 | | — | | | 1,392 | | 98 | | (41 | ) | 1,448 | | — | |
|
CMBS | 2,090 | | 101 | | (23 | ) | 2,168 | | (4 | ) | | 2,275 | | 106 | | (34 | ) | 2,347 | | (3 | ) |
|
Corporate | 15,670 | | 1,485 | | (113 | ) | 17,042 | | (4 | ) | | 15,913 | | 1,196 | | (192 | ) | 16,917 | | (6 | ) |
|
Foreign govt./govt. agencies | 996 | | 31 | | (86 | ) | 941 | | — | | | 1,267 | | 27 | | (117 | ) | 1,177 | | — | |
|
Municipal | 955 | | 54 | | (19 | ) | 990 | | — | | | 988 | | 26 | | (49 | ) | 965 | | — | |
|
RMBS | 2,329 | | 61 | | (31 | ) | 2,359 | | (2 | ) | | 2,419 | | 60 | | (48 | ) | 2,431 | | (3 | ) |
|
U.S. Treasuries | 1,655 | | 69 | | (2 | ) | 1,722 | | — | | | 1,762 | | 1 | | (14 | ) | 1,749 | | — | |
|
Total fixed maturities, AFS | 25,971 | | 1,909 | | (350 | ) | 27,529 | | (12 | ) | | 27,188 | | 1,527 | | (551 | ) | 28,163 | | (14 | ) |
|
Equity securities, AFS | 306 | | 31 | | (22 | ) | 315 | | — | | | 362 | | 35 | | (25 | ) | 372 | | — | |
|
Total AFS securities | $ | 26,277 | | $ | 1,940 | | $ | (372 | ) | $ | 27,844 | | $ | (12 | ) | | $ | 27,550 | | $ | 1,562 | | $ | (576 | ) | $ | 28,535 | | $ | (14 | ) |
|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of March 31, 2014 and December 31, 2013. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | Gross unrealized gains (losses) exclude the change in fair value of bifurcated embedded derivative features of certain securities. Subsequent changes in fair value will be recorded in net realized capital gains (losses). | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
The following table presents the Company’s fixed maturities, AFS, by contractual maturity year. |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | | | | | | | | | | | | | | | | | | | | | | | | |
Contractual Maturity | Amortized Cost | Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | |
One year or less | $ | 1,738 | | $ | 1,762 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Over one year through five years | 5,368 | | 5,610 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Over five years through ten years | 3,776 | | 3,960 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Over ten years | 8,394 | | 9,363 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Subtotal | 19,276 | | 20,695 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Mortgage-backed and asset-backed securities | 6,695 | | 6,834 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Total fixed maturities, AFS | $ | 25,971 | | $ | 27,529 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment speeds (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity. |
Concentration of Credit Risk |
The Company aims to maintain a diversified investment portfolio including issuer, sector and geographic stratification, where applicable, and has established certain exposure limits, diversification standards and review procedures to mitigate credit risk. |
As of March 31, 2014, the Company's only exposure to any credit concentration risk of a single issuer equal to or greater than 10% of the Company’s stockholder’s equity, other than U.S. government and certain U.S. government securities, was the Government of Japan, which represented $785, or 10% of stockholders' equity and 2% of total invested assets. As of March 31, 2013, the Company's only exposure to any concentration of credit risk of a single issuer equal to or greater than 10% of the Company’s stockholder’s equity other than the U.S. government and certain U.S. government agencies, was the Government of Japan,which represented $868, or 10% of stockholders' equity and 1.9% of total invested assets. For further discussion of concentration of credit risk, see the Concentration of Credit Risk section in Note 4 of Notes to Consolidated Financial Statements in the Company’s 2013 Form 10-K Annual Report. |
Securities Unrealized Loss Aging |
The following tables present the Company’s unrealized loss aging for AFS securities by type and length of time the security was in a continuous unrealized loss position. |
| | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | | | | |
| Less Than 12 Months | 12 Months or More | Total | | | | |
| Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses | | | | |
ABS | $ | 145 | | $ | 144 | | $ | (1 | ) | $ | 372 | | $ | 330 | | $ | (42 | ) | $ | 517 | | $ | 474 | | $ | (43 | ) | | | | |
| | | |
CDOs [1] | 82 | | 81 | | (1 | ) | 1,002 | | 969 | | (32 | ) | 1,084 | | 1,050 | | (33 | ) | | | | |
| | | |
CMBS | 255 | | 246 | | (9 | ) | 317 | | 303 | | (14 | ) | 572 | | 549 | | (23 | ) | | | | |
| | | |
Corporate | 1,532 | | 1,494 | | (38 | ) | 711 | | 636 | | (75 | ) | 2,243 | | 2,130 | | (113 | ) | | | | |
| | | |
Foreign govt./govt. agencies | 226 | | 212 | | (14 | ) | 315 | | 243 | | (72 | ) | 541 | | 455 | | (86 | ) | | | | |
| | | |
Municipal | 285 | | 275 | | (10 | ) | 85 | | 76 | | (9 | ) | 370 | | 351 | | (19 | ) | | | | |
| | | |
RMBS | 514 | | 509 | | (5 | ) | 401 | | 375 | | (26 | ) | 915 | | 884 | | (31 | ) | | | | |
| | | |
U.S. Treasuries | 349 | | 347 | | (2 | ) | — | | — | | — | | 349 | | 347 | | (2 | ) | | | | |
| | | |
Total fixed maturities, AFS | 3,388 | | 3,308 | | (80 | ) | 3,203 | | 2,932 | | (270 | ) | 6,591 | | 6,240 | | (350 | ) | | | | |
| | | |
Equity securities, AFS | 48 | | 46 | | (2 | ) | 130 | | 110 | | (20 | ) | 178 | | 156 | | (22 | ) | | | | |
| | | |
Total securities in an unrealized loss position | $ | 3,436 | | $ | 3,354 | | $ | (82 | ) | $ | 3,333 | | $ | 3,042 | | $ | (290 | ) | $ | 6,769 | | $ | 6,396 | | $ | (372 | ) | | | | |
| | | |
|
| | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2013 | | | | |
| Less Than 12 Months | 12 Months or More | Total | | | | |
| Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses | Amortized Cost | Fair Value | Unrealized Losses | | | | |
ABS | $ | 288 | | $ | 286 | | $ | (2 | ) | $ | 418 | | $ | 364 | | $ | (54 | ) | $ | 706 | | $ | 650 | | $ | (56 | ) | | | | |
| | | |
CDOs [1] | 64 | | 63 | | (1 | ) | 1,185 | | 1,144 | | (40 | ) | 1,249 | | 1,207 | | (41 | ) | | | | |
| | | |
CMBS | 437 | | 423 | | (14 | ) | 392 | | 372 | | (20 | ) | 829 | | 795 | | (34 | ) | | | | |
| | | |
Corporate | 2,449 | | 2,360 | | (89 | ) | 799 | | 696 | | (103 | ) | 3,248 | | 3,056 | | (192 | ) | | | | |
| | | |
Foreign govt./govt. agencies | 542 | | 501 | | (41 | ) | 303 | | 227 | | (76 | ) | 845 | | 728 | | (117 | ) | | | | |
| | | |
Municipal | 508 | | 475 | | (33 | ) | 99 | | 83 | | (16 | ) | 607 | | 558 | | (49 | ) | | | | |
| | | |
RMBS | 922 | | 909 | | (13 | ) | 475 | | 440 | | (35 | ) | 1,397 | | 1,349 | | (48 | ) | | | | |
| | | |
U.S. Treasuries | 1,456 | | 1,442 | | (14 | ) | — | | — | | — | | 1,456 | | 1,442 | | (14 | ) | | | | |
| | | |
Total fixed maturities, AFS | 6,666 | | 6,459 | | (207 | ) | 3,671 | | 3,326 | | (344 | ) | 10,337 | | 9,785 | | (551 | ) | | | | |
| | | |
Equity securities, AFS | 77 | | 73 | | (4 | ) | 135 | | 114 | | (21 | ) | 212 | | 187 | | (25 | ) | | | | |
| | | |
Total securities in an unrealized loss position | $ | 6,743 | | $ | 6,532 | | $ | (211 | ) | $ | 3,806 | | $ | 3,440 | | $ | (365 | ) | $ | 10,549 | | $ | 9,972 | | $ | (576 | ) | | | | |
| | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Unrealized losses exclude the change in fair value of bifurcated embedded derivative features of certain securities. Subsequent changes in fair value are recorded in net realized capital gains (losses). | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
As of March 31, 2014, AFS securities in an unrealized loss position, consisted of 1,631 securities, primarily related to floating rate corporate and foreign government and government agencies, which are depressed due to an increase in interest rates since the securities were purchased and/or declines in the value of the currency in which the assets are denominated. As of March 31, 2014, 94% of these securities were depressed less than 20% of cost or amortized cost. The decrease in unrealized losses during 2014 was primarily attributable to a decrease in interest rates and tighter credit spreads. |
Most of the securities depressed for twelve months or more relate to certain floating rate corporate securities with greater than 10 years to maturity concentrated in the financial services sector, foreign government and government agencies, and structured securities with exposure to commercial and residential real estate. Corporate financial services securities are primarily depressed because the securities have floating-rate coupons and/or long-dated maturities. Unrealized losses on foreign government securities are primarily due to depreciation of the Japanese yen in relation to the U.S. dollar. Although credit spreads have continued to tighten over the past five years, current market spreads continue to be wider than spreads at the securities' respective purchase dates for structured securities with exposure to commercial and residential real estate largely due to reduced liquidity as a result of economic and market uncertainties regarding future performance of certain commercial and residential real estate backed securities. The majority of these securities have a floating-rate coupon referenced to a market index that has declined substantially. In addition, equity securities include investment grade perpetual preferred securities that contain “debt-like” characteristics where the decline in fair value is not attributable to issuer-specific credit deterioration, none of which have, nor are expected to, miss a periodic dividend payment. These securities have been depressed due to the securities’ floating-rate coupon in the current low interest rate environment, general market credit spread widening since the date of purchase and the long-dated nature of the securities. The Company neither has an intention to sell nor does it expect to be required to sell the securities outlined above. |
Mortgage Loans |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 | | | | | | | | | | | | | |
| Amortized Cost [1] | Valuation Allowance | Carrying Value | Amortized Cost [1] | Valuation Allowance | Carrying Value | | | | | | | | | | | | | |
Total commercial mortgage loans | $ | 3,327 | | $ | (12 | ) | $ | 3,315 | | $ | 3,482 | | $ | (12 | ) | $ | 3,470 | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Amortized cost represents carrying value prior to valuation allowances, if any. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
As of March 31, 2014, and December 31, 2013, the carrying value of mortgage loans associated with the valuation allowance was $93 and $86, respectively . Included in the table above are mortgage loans held-for-sale with a carrying value and valuation allowance of $40 and $1, respectively, as of March 31, 2014 and $53 and $3, respectively, as of December 31, 2013. The carrying value of these loans is included in mortgage loans in the Company’s Condensed Consolidated Balance Sheets. As of March 31, 2014, loans within the Company’s mortgage loan portfolio that have had extensions or restructurings other than what is allowable under the original terms of the contract are immaterial. |
The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial. |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended March 31, | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2014 | 2013 | | | | | | | | | | | | | | | | | | | | | | | | | |
Balance, beginning of period | $ | (12 | ) | $ | (14 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
(Additions)/Reversals | — | | (1 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Deductions | — | | 2 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Balance, end of period | $ | (12 | ) | $ | (13 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
The weighted-average LTV ratio of the Company’s commercial mortgage loan portfolio was 58% as of March 31, 2014, while the weighted-average LTV ratio at origination of these loans was 63%. LTV ratios compare the loan amount to the value of the underlying property collateralizing the loan. The loan values are updated no less than annually through property level reviews of the portfolio. Factors considered in the property valuation include, but are not limited to, actual and expected property cash flows, geographic market data and capitalization rates. DSCR compare a property’s net operating income to the borrower’s principal and interest payments. The weighted average DSCR of the Company’s commercial mortgage loan portfolio was 2.28x as of March 31, 2014. The Company held no delinquent commercial mortgage loans as of March 31, 2014. |
The following table presents the carrying value of the Company’s commercial mortgage loans by LTV and DSCR. |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Commercial Mortgage Loans Credit Quality | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 | | | | | | | | | | | | | | | | | | | | | | | |
Loan-to-value | Carrying Value | Avg. Debt-Service Coverage Ratio | Carrying Value | Avg. Debt-Service Coverage Ratio | | | | | | | | | | | | | | | | | | | | | | | |
Greater than 80% | $ | 29 | | 1.08x | $ | 35 | | 1.15x | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
65% - 80% | 675 | | 2.01x | 777 | | 1.94x | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Less than 65% | 2,611 | | 2.37x | 2,658 | | 2.34x | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Total commercial mortgage loans | $ | 3,315 | | 2.28x | $ | 3,470 | | 2.23x | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
The following tables present the carrying value of the Company’s mortgage loans by region and property type. |
| | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Mortgage Loans by Region | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 | | | | | | | | | | | | | | | | | | | | | | | |
| Carrying Value | Percent of Total | Carrying Value | Percent of Total | | | | | | | | | | | | | | | | | | | | | | | |
East North Central | $ | 73 | | 2.20% | $ | 79 | | 2.30% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Middle Atlantic | 247 | | 7.50% | 255 | | 7.30% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Mountain | 40 | | 1.20% | 40 | | 1.20% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
New England | 146 | | 4.40% | 163 | | 4.70% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Pacific | 934 | | 28.20% | 1,019 | | 29.40% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
South Atlantic | 560 | | 16.90% | 548 | | 15.80% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
West North Central | 17 | | 0.50% | 17 | | 0.50% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
West South Central | 124 | | 3.70% | 144 | | 4.10% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Other [1] | 1,174 | | 35.40% | 1,205 | | 34.70% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Total mortgage loans | $ | 3,315 | | 100.00% | $ | 3,470 | | 100.00% | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Primarily represents loans collateralized by multiple properties in various regions. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Mortgage Loans by Property Type | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 | | | | | | | | | | | | | | | | | | | | | |
| Carrying Value | Percent of Total | Carrying Value | Percent of Total | | | | | | | | | | | | | | | | | | | | | |
Commercial | | | | | | | | | | | | | | | | | | | | | | | | | |
Agricultural | $ | 56 | | 1.7 | % | $ | 93 | | 2.7 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Industrial | 1,151 | | 34.7 | % | 1,182 | | 34.1 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Lodging | 27 | | 0.8 | % | 27 | | 0.8 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Multifamily | 559 | | 16.9 | % | 576 | | 16.6 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Office | 683 | | 20.6 | % | 723 | | 20.8 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Retail | 725 | | 21.9 | % | 745 | | 21.5 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Other | 114 | | 3.4 | % | 124 | | 3.5 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Total mortgage loans | $ | 3,315 | | 100 | % | $ | 3,470 | | 100 | % | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Variable Interest Entities |
The Company is involved with various special purpose entities and other entities that are deemed to be VIEs primarily as a collateral or investment manager and as an investor through normal investment activities. |
A VIE is an entity that either has investors that lack certain essential characteristics of a controlling financial interest or lacks sufficient funds to finance its own activities without financial support provided by other entities. |
The Company performs ongoing qualitative assessments of its VIEs to determine whether the Company has a controlling financial interest in the VIE and therefore is the primary beneficiary. The Company is deemed to have a controlling financial interest when it has both the ability to direct the activities that most significantly impact the economic performance of the VIE and the obligation to absorb losses or right to receive benefits from the VIE that could potentially be significant to the VIE. Based on the Company’s assessment, if it determines it is the primary beneficiary, the Company consolidates the VIE in the Company’s Condensed Consolidated Financial Statements. |
Consolidated VIEs |
The following table presents the carrying value of assets and liabilities, and the maximum exposure to loss relating to the VIEs for which the Company is the primary beneficiary. Creditors have no recourse against the Company in the event of default by these VIEs nor does the Company have any implied or unfunded commitments to these VIEs. The Company’s financial or other support provided to these VIEs is limited to its collateral or investment management services and original investment. |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2014 | December 31, 2013 | | | | | | | | | | | | | |
| Total Assets | Total Liabilities [1] | Maximum Exposure to Loss [2] | Total Assets | Total Liabilities [1] | Maximum Exposure to Loss [2] | | | | | | | | | | | | | |
CDOs [3] | $ | 8 | | $ | 9 | | $ | — | | $ | 12 | | $ | 13 | | $ | — | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
Investment funds [4] | 137 | | 20 | | 121 | | 134 | | 20 | | 119 | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
Limited partnerships | 3 | | 1 | | 2 | | 4 | | 2 | | 2 | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
Total | $ | 148 | | $ | 30 | | $ | 123 | | $ | 150 | | $ | 35 | | $ | 121 | | | | | | | | | | | | | | |
| | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Included in other liabilities in the Company’s Condensed Consolidated Balance Sheets. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | The maximum exposure to loss represents the maximum loss amount that the Company could recognize as a reduction in net investment income or as a realized capital loss and is the cost basis of the Company’s investment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[3] | Total assets included in fixed maturities, AFS in the Company’s Condensed Consolidated Balance | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Sheets. |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[4] | Total assets included in fixed maturities, FVO, short-term investments, and equity, AFS in the Company’s Condensed Consolidated Balance Sheets. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
CDOs represent structured investment vehicles for which the Company has a controlling financial interest as it provides collateral management services, earns a fee for those services and also holds investments in the securities issued by these vehicles. Investment funds represents wholly-owned fixed income funds for which the Company has exclusive management and control including management of investment securities which is the activity that most significantly impacts its economic performance. Limited partnerships represent one hedge fund of funds for which the Company holds a majority interest in the fund as an investment. |
Non-Consolidated VIEs |
The Company, through normal investment activities, makes passive investments in structured securities issued by VIEs for which the Company is not the manager which are included in ABS, CDOs, CMBS and RMBS in the Available-for-Sale Securities table and fixed maturities, FVO, in the Company’s Condensed Consolidated Balance Sheets. The Company has not provided financial or other support with respect to these investments other than its original investment. For these investments, the Company determined it is not the primary beneficiary due to the relative size of the Company’s investment in comparison to the principal amount of the structured securities issued by the VIEs, the level of credit subordination which reduces the Company’s obligation to absorb losses or right to receive benefits and the Company’s inability to direct the activities that most significantly impact the economic performance of the VIEs. The Company’s maximum exposure to loss on these investments is limited to the amount of the Company’s investment. |
Repurchase and Dollar Roll Agreements and Other Collateral Transactions |
The Company enters into repurchase agreements and dollar roll transactions to manage liquidity or to earn incremental spread income. A repurchase agreement is a transaction in which one party (transferor) agrees to sell securities to another party (transferee) in return for cash (or securities), with a simultaneous agreement to repurchase the same securities at a specified price at a later date. A dollar roll is a type of repurchase agreement where a mortgage backed security is sold with an agreement to repurchase substantially the same security at a specified time in the future. These transactions are generally short-term in nature, and therefore, the carrying amounts of these instruments approximate fair value. |
As part of repurchase agreements and dollar roll transactions, the Company transfers collateral of U.S. government and government agency securities and receives cash. For the repurchase agreements, the Company obtains cash in an amount equal to at least 95% of the fair value of the securities transferred. The agreements contain contractual provisions that require additional collateral to be transferred when necessary and provide the counterparty the right to sell or re-pledge the securities transferred. The cash received from the repurchase program is typically invested in short-term investments or fixed maturities. Repurchase agreements include master netting provisions that provide the counterparties the right to offset claims and apply securities held by them in respect of their obligations in the event of a default. Although the Company has the contractual right to offset claims, fixed maturities do not meet the specific conditions for net presentation under U.S. GAAP. The Company accounts for the repurchase agreements and dollar roll transactions as collateralized borrowings. The securities transferred under repurchase agreements and dollar roll transactions are included in fixed maturities, AFS with the obligation to repurchase those securities recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets. |
As of March 31, 2014, the Company reported financial collateral pledged, related to dollar roll transactions, with a fair value of $41 in fixed maturities, AFS with a corresponding obligation to repurchase $41 reported in other liabilities. The Company had no outstanding dollar roll transactions as of December 31, 2013. The Company had no outstanding repurchase agreements as of March 31, 2014 and December 31, 2013. |
The Company is required by law to deposit securities with government agencies in states where it conducts business. As of March 31, 2014 and December 31, 2013 the fair value of securities on deposit was approximately $13 and $13, respectively. |
Refer to Derivative Collateral Arrangements section of this note for disclosure of collateral in support of derivative transactions. |
Derivative Instruments |
The Company utilizes a variety of OTC, OTC-cleared and exchange traded derivative instruments as a part of its overall risk management strategy as well as to enter into replication transactions. Derivative instruments are used to manage risk associated with interest rate, equity market, credit spread, issuer default, price, and currency exchange rate risk or volatility. Replication transactions are used as an economical means to synthetically replicate the characteristics and performance of assets that would be permissible investments under the Company’s investment policies. The Company also may enter into and has previously issued financial instruments and products that either are accounted for as free-standing derivatives, such as certain reinsurance contracts, or may contain features that are deemed to be embedded derivative instruments, such as the GMWB rider included with certain variable annuity products. |
Strategies that qualify for hedge accounting |
Certain derivatives that the Company enters into satisfy the hedge accounting requirements as outlined in Note 1 - Basis of Presentation and Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements, included in The Hartford’s 2013 Form 10-K Annual Report. Typically, these hedge relationships include interest rate and foreign currency swaps where the terms or expected cash flows of the hedged item closely match the terms of the swap. The swaps are typically used to manage interest rate duration of certain fixed maturity securities or liability contracts. The Company also formerly entered into swaps to convert securities or liabilities denominated in a foreign currency to U.S. dollars. The hedge strategies by hedge accounting designation include: |
Cash flow hedges |
Interest rate swaps are predominantly used to manage portfolio duration and better match cash receipts from assets with cash disbursements required to fund liabilities. These derivatives primarily convert interest receipts on floating-rate fixed maturity securities to fixed rates. The Company also enters into forward starting swap agreements primarily to hedge interest rate risk inherent in the assumptions used to price certain liabilities. |
Foreign currency swaps are used to convert foreign currency-denominated cash flows related to certain investment receipts and liability payments to U.S. dollars in order to reduce cash flow fluctuations due to changes in currency rates. |
Fair value hedges |
Interest rate swaps are used to hedge the changes in fair value of fixed maturity securities due to fluctuations in interest rates. Foreign currency swaps were formally used to hedge the changes in fair value of certain foreign currency-denominated fixed rate liabilities due to changes in foreign currency rates by swapping the fixed foreign payments to floating rate U.S. dollar denominated payments. |
Non-qualifying strategies |
Derivative relationships that do not qualify for hedge accounting (“non-qualifying strategies”) primarily include the hedge programs for the Company's U.S. and international variable annuity products as well as the hedging and replication strategies that utilize credit default swaps. In addition, hedges of interest rate and foreign currency risk of certain fixed maturities and liabilities do not qualify for hedge accounting. The non-qualifying strategies include: |
Interest rate swaps, swaptions and futures |
The Company uses interest rate swaps, swaptions and futures to manage duration between assets and liabilities in certain investment portfolios. In addition, the Company enters into interest rate swaps to terminate existing swaps, thereby offsetting the changes in value of the original swap. As of March 31, 2014 and December 31, 2013 the notional amount of interest rate swaps in offsetting relationships was $4.5 billion. |
Foreign currency swaps and forwards |
The Company enters into foreign currency swaps and forwards to convert the foreign currency exposures of certain foreign currency-denominated fixed maturity investments to U.S. dollars. |
Japan 3Win foreign currency swaps |
The Company formerly offered certain variable annuity products with a guaranteed minimum income benefit ("GMIB") rider through a wholly-owned Japanese subsidiary. The GMIB rider is reinsured to a wholly-owned U.S. subsidiary which invests in U.S. dollar denominated assets to support the liability. The U.S. subsidiary entered into pay U.S. dollar, receive yen swap contracts to hedge the currency and yen interest rate exposure between the U.S. dollar denominated assets and the yen denominated fixed liability reinsurance payments. |
Japanese fixed annuity hedging instruments |
The Company formerly offered a yen denominated fixed annuity product through a wholly-owned Japanese subsidiary and reinsured to a wholly-owned U.S. subsidiary. The U.S. subsidiary invests in U.S. dollar denominated securities to support the yen denominated fixed liability payments and entered into currency rate swaps to hedge the foreign currency exchange rate and yen interest rate exposures that exist as a result of U.S. dollar assets backing the yen denominated liability. |
Credit contracts |
Credit default swaps are used to purchase credit protection on an individual entity or referenced index to economically hedge against default risk and credit-related changes in value on fixed maturity securities. Credit default swaps are also used to assume credit risk related to an individual entity or referenced index as a part of replication transactions. These contracts require the Company to pay or receive a periodic fee in exchange for compensation from the counterparty should the referenced security issuers experience a credit event, as defined in the contract. The Company is also exposed to credit risk related to credit derivatives embedded within certain fixed maturity securities. These securities are primarily comprised of structured securities that contain credit derivatives that reference a standard index of corporate securities. In addition, the Company enters into credit default swaps to terminate existing credit default swaps, thereby offsetting the changes in value of the original swap going forward. |
Equity index swaps and options |
The Company formerly offered certain equity indexed products which may contain an embedded derivative that requires bifurcation. The Company has entered into equity index swaps and options to economically hedge the equity volatility risk associated with these embedded derivatives. The Company also enters into equity index options and futures with the purpose of hedging the impact of an adverse equity market environment on the investment portfolio. |
U.S. GMWB derivatives, net |
The Company formerly offered certain variable annuity products with GMWB riders in the U.S. The GMWB product is a bifurcated embedded derivative (“U.S. GMWB product derivatives”) that has a notional value equal to the GRB. The Company uses reinsurance contracts to transfer a portion of its risk of loss due to U.S GMWB. The reinsurance contracts covering U.S. GMWB (“U.S. GMWB reinsurance contracts”) are accounted for as free-standing derivatives with a notional amount equal to the GRB amount. |
The Company utilizes derivatives (“U.S. GMWB hedging instruments”) as part of an actively managed program designed to hedge a portion of the capital market risk exposures of the non-reinsured GMWB riders due to changes in interest rates, equity market levels, and equity volatility. These derivatives include customized swaps, interest rate swaps and futures, and equity swaps, options and futures, on certain indices including the S&P 500 index, EAFE index and NASDAQ index. The following table presents notional and fair value for U.S. GMWB hedging instruments. |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Notional Amount | Fair Value | | | | | | | | | | | | | | | | | | | |
| 31-Mar-14 | December 31, 2013 | 31-Mar-14 | December 31, 2013 | | | | | | | | | | | | | | | | | | | |
Customized swaps | $ | 7,561 | | $ | 7,839 | | $ | 71 | | $ | 74 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Equity swaps, options, and futures | 3,888 | | 4,237 | | 32 | | 44 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Interest rate swaps and futures | 3,975 | | 6,615 | | (2 | ) | (77 | ) | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Total | $ | 15,424 | | $ | 18,691 | | $ | 101 | | $ | 41 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
U.S. macro hedge program |
The Company utilizes equity options and swaps to partially hedge against a decline in the equity markets and the resulting statutory surplus and capital impact primarily arising from GMDB and GMWB obligations. The following table represents notional and fair value for the U.S. macro hedge program. |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Notional Amount | Fair Value | | | | | | | | | | | | | | | | | | | |
| 31-Mar-14 | December 31, 2013 | 31-Mar-14 | December 31, 2013 | | | | | | | | | | | | | | | | | | | |
Equity options and swaps | 7,596 | | 9,934 | | 133 | | 139 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Total | $ | 7,596 | | $ | 9,934 | | $ | 133 | | $ | 139 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
International program |
The Company formerly offered certain variable annuity products in Japan with GMWB or GMAB riders, which are bifurcated embedded derivatives (“International program product derivatives”). The GMWB provides the policyholder with a GRB which is generally equal to premiums less withdrawals. If the policyholder’s account value is reduced to the specified level through a combination of market declines and withdrawals but the GRB still has value, the Company is obligated to continue to make annuity payments to the policyholder until the GRB is exhausted. The GMAB provides the policyholder with their initial deposit in a lump sum after a specified waiting period. The notional amount of the International program product derivatives are the foreign currency denominated GRBs converted to U.S. dollars at the current foreign spot exchange rate as of the reporting period date. |
The Company enters into derivative contracts (“International program hedging instruments”) to hedge a portion of the capital market risk exposures associated with the guaranteed benefits associated with the international variable annuity contracts. The hedging derivatives are comprised of equity futures, options, swaps and currency forwards and options to hedge against a decline in the debt and equity markets or changes in foreign currency exchange rates and the resulting statutory surplus and capital impact primarily arising from guaranteed minimum death benefits ("GMDB"), GMIB and GMWB obligations issued in Japan. The Company also enters into foreign currency denominated interest rate swaps and swaptions to hedge the interest rate exposure related to the potential annuitization of certain benefit obligations. The following table represents notional and fair value for the international program hedging instruments. |
| | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Notional Amount | Fair Value | | | | | | | | | | | | | | | | | | | |
| March 31, | December 31, 2013 | March 31, | December 31, 2013 | | | | | | | | | | | | | | | | | | | |
2014 | 2014 | | | | | | | | | | | | | | | | | | | |
Credit derivatives | $ | 350 | | $ | 350 | | $ | — | | $ | 5 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Currency forwards [1] | 12,254 | | 8,778 | | 32 | | 24 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Currency options | 4,774 | | 8,408 | | (15 | ) | (58 | ) | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Equity futures | 473 | | 999 | | — | | — | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Equity options | 949 | | 1,022 | | (65 | ) | (63 | ) | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Equity swaps | 2,121 | | 3,830 | | (50 | ) | (95 | ) | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Customized swaps | — | | — | | — | | — | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Interest rate futures | 551 | | 566 | | — | | — | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Interest rate swaps and swaptions | 34,216 | | 33,072 | | 146 | | 160 | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
Total | $ | 55,688 | | $ | 57,025 | | $ | 48 | | $ | (27 | ) | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | As of March 31, 2014 and December 31, 2013 net notional amounts are $(0.8) billion and $(1.6) billion, respectively, which include $5.7 billion and $3.6 billion, respectively, related to long positions and $6.5 billion and $5.2 billion, respectively, related to short positions. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GMAB, GMWB and GMIB assumed reinsurance contracts |
The Company reinsures the GMAB, GMWB, and GMIB embedded derivatives for host variable annuity contracts written by HLIKK. The reinsurance contracts are accounted for as free-standing derivative contracts. The notional amount of the reinsurance contracts is the yen denominated GRB balance value converted at the period-end yen to U.S. dollar foreign spot exchange rate. For further information on this transaction, refer to Note 11 - Transactions with Affiliates of Notes to Condensed Consolidated Financial Statements. |
Coinsurance and modified coinsurance reinsurance contracts |
During 2010, a subsidiary entered into a coinsurance with funds withheld and modified coinsurance reinsurance agreement with an affiliated captive reinsurer, which creates an embedded derivative. In addition, provisions of this agreement include reinsurance to cede a portion of direct written U.S. GMWB riders, which is accounted for as an embedded derivative. Additional provisions of this agreement cede variable annuity contract GMAB, GMWB and GMIB riders reinsured by the Company that have been assumed from HLIKK and is accounted for as a free-standing derivative. For further information on this transaction, refer to Note 11 - Transactions with Affiliates and Note 15 - Subsequent Events of Notes to Condensed Consolidated Financial Statements. |
As of March 31, 2014 and December 31, 2013 the Company had approximately $1.3 billion of invested assets supporting other policyholder funds and benefits payable reinsured under a modified coinsurance arrangement in connection with the sale of the Individual Life business structured as a reinsurance transaction. The assets are primarily held in a trust established by the Company. The Company pays or receives cash quarterly to settle the results of the reinsured business, including the investment results. As a result of this modified coinsurance arrangement, the Company has an embedded derivative that transfers to the reinsurer certain unrealized changes in fair value due to interest rate and credit risks of these assets. The notional amounts of the reinsurance contracts are the invested assets that are carried at fair value supporting the reinsured reserves. |
Derivative Balance Sheet Classification |
The following table summarizes the balance sheet classification of the Company’s derivative related fair value amounts as well as the gross asset and liability fair value amounts. For reporting purposes, the Company has elected to offset the fair value amounts, income accruals, and related cash collateral receivables and payables of OTC derivative instruments executed in a legal entity and with the same counterparty under a master netting agreement, which provides the Company with the legal right of offset. The Company has also elected to offset the fair value amounts, income accruals and related cash collateral receivables and payables of OTC-cleared derivative instruments based on clearing house agreements. The fair value amounts presented below do not include income accruals or related cash collateral receivables and payables, which are netted with derivative fair value amounts to determine balance sheet presentation. Derivatives in the Company’s separate accounts, where the associated gains and losses accrue directly to policyholders, are not included. The Company’s derivative instruments are held for risk management purposes, unless otherwise noted in the following table. The notional amount of derivative contracts represents the basis upon which pay or receive amounts are calculated and is presented in the table to quantify the volume of the Company’s derivative activity. Notional amounts are not necessarily reflective of credit risk. The tables below exclude investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 3 - Fair Value Measurements. |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Net Derivatives | Asset Derivatives | Liability Derivatives | | | | | | | |
| Notional Amount | Fair Value | Fair Value | Fair Value | | | | | | | |
Hedge Designation/ Derivative Type | Mar 31, 2014 | 31-Dec-13 | Mar 31, 2014 | 31-Dec-13 | Mar 31, 2014 | 31-Dec-13 | Mar 31, 2014 | 31-Dec-13 | | | | | | | |
Cash flow hedges | | | | | | | | | | | | | | | |
Interest rate swaps | $ | 2,966 | | $ | 3,215 | | $ | 25 | | $ | 16 | | $ | 43 | | $ | 49 | | $ | (18 | ) | $ | (33 | ) | | | | | | | |
| | | | | | |
Foreign currency swaps | 143 | | 143 | | (6 | ) | (5 | ) | 2 | | 2 | | (8 | ) | (7 | ) | | | | | | | |
| | | | | | |
Total cash flow hedges | 3,109 | | 3,358 | | 19 | | 11 | | 45 | | 51 | | (26 | ) | (40 | ) | | | | | | | |
| | | | | | |
Fair value hedges | | | | | | | | | | | | | | | |
Interest rate swaps | 699 | | 1,261 | | (25 | ) | (24 | ) | 1 | | 2 | | (26 | ) | (26 | ) | | | | | | | |
| | | | | | |
Total fair value hedges | 699 | | 1,261 | | (25 | ) | (24 | ) | 1 | | 2 | | (26 | ) | (26 | ) | | | | | | | |
| | | | | | |
Non-qualifying strategies | | | | | | | | | | | | | | | |
Interest rate contracts | | | | | | | | | | | | | | | |
Interest rate swaps, swaptions, caps, floors, and futures | 4,679 | | 4,633 | | (355 | ) | (368 | ) | 193 | | 123 | | (548 | ) | (491 | ) | | | | | | | |
| | | | | | |
Foreign exchange contracts | | | | | | | | | | | | | | | |
Foreign currency swaps and forwards | 107 | | 118 | | (5 | ) | (4 | ) | 6 | | 6 | | (11 | ) | (10 | ) | | | | | | | |
| | | | | | |
Japan 3Win foreign currency swaps | 1,571 | | 1,571 | | (338 | ) | (354 | ) | — | | — | | (338 | ) | (354 | ) | | | | | | | |
| | | | | | |
Japanese fixed annuity hedging instruments | 1,381 | | 1,436 | | (2 | ) | (6 | ) | 88 | | 88 | | (90 | ) | (94 | ) | | | | | | | |
| | | | | | |
Credit contracts | | | | | | | | | | | | | | | |
Credit derivatives that purchase credit protection | 220 | | 243 | | (4 | ) | (4 | ) | — | | — | | (4 | ) | (4 | ) | | | | | | | |
| | | | | | |
Credit derivatives that assume credit risk [1] | 1,356 | | 1,507 | | 17 | | 27 | | 19 | | 28 | | (2 | ) | (1 | ) | | | | | | | |
| | | | | | |
Credit derivatives in offsetting positions | 2,785 | | 3,501 | | (2 | ) | (3 | ) | 32 | | 35 | | (34 | ) | (38 | ) | | | | | | | |
| | | | | | |
Equity contracts | | | | | | | | | | | | | | | |
Equity index swaps and options | 129 | | 131 | | (3 | ) | (2 | ) | 18 | | 18 | | (21 | ) | (20 | ) | | | | | | | |
| | | | | | |
Variable annuity hedge program | | | | | | | | | | | | | | | |
U.S. GMWB product derivatives [2] | 21,195 | | 21,512 | | (24 | ) | (36 | ) | — | | — | | (24 | ) | (36 | ) | | | | | | | |
| | | | | | |
U.S. GMWB reinsurance contracts | 4,280 | | 4,508 | | 30 | | 29 | | 30 | | 29 | | — | | — | | | | | | | | |
| | | | | | |
U.S. GMWB hedging instruments | 15,424 | | 18,691 | | 101 | | 41 | | 278 | | 333 | | (177 | ) | (292 | ) | | | | | | | |
| | | | | | |
U.S. macro hedge program | 7,596 | | 9,934 | | 133 | | 139 | | 166 | | 178 | | (33 | ) | (39 | ) | | | | | | | |
| | | | | | |
International program hedging instruments | 55,688 | | 57,025 | | 48 | | (27 | ) | 441 | | 649 | | (393 | ) | (676 | ) | | | | | | | |
| | | | | | |
Other | | | | | | | | | | | | | | | |
GMAB, GMWB, and GMIB reinsurance contracts | 11,080 | | 11,999 | | (512 | ) | (540 | ) | — | | — | | (512 | ) | (540 | ) | | | | | | | |
| | | | | | |
Coinsurance and modified coinsurance reinsurance contracts | 28,387 | | 29,423 | | (559 | ) | (427 | ) | 283 | | 383 | | (842 | ) | (810 | ) | | | | | | | |
| | | | | | |
Total non-qualifying strategies | 155,878 | | 166,232 | | (1,475 | ) | (1,535 | ) | 1,554 | | 1,870 | | (3,029 | ) | (3,405 | ) | | | | | | | |
| | | | | | |
Total cash flow hedges, fair value hedges, and non-qualifying strategies | $ | 159,686 | | $ | 170,851 | | $ | (1,481 | ) | $ | (1,548 | ) | $ | 1,600 | | $ | 1,923 | | $ | (3,081 | ) | $ | (3,471 | ) | | | | | | | |
| | | | | | |
Balance Sheet Location | | | | | | | | | | | | | | | |
Fixed maturities, available-for-sale | $ | 199 | | $ | 196 | | $ | (1 | ) | $ | (1 | ) | $ | — | | $ | — | | $ | (1 | ) | $ | (1 | ) | | | | | | | |
| | | | | | |
Other investments | 42,463 | | 40,564 | | 169 | | 272 | | 550 | | 721 | | (381 | ) | (449 | ) | | | | | | | |
| | | | | | |
Other liabilities | 52,023 | | 62,590 | | (563 | ) | (825 | ) | 738 | | 789 | | (1,301 | ) | (1,614 | ) | | | | | | | |
| | | | | | |
Consumer notes | 9 | | 9 | | (2 | ) | (2 | ) | — | | — | | (2 | ) | (2 | ) | | | | | | | |
| | | | | | |
Reinsurance recoverable | 32,667 | | 33,931 | | (529 | ) | (398 | ) | 312 | | 413 | | (841 | ) | (811 | ) | | | | | | | |
| | | | | | |
Other policyholder funds and benefits payable | 32,325 | | 33,561 | | (555 | ) | (594 | ) | — | | — | | (555 | ) | (594 | ) | | | | | | | |
| | | | | | |
Total derivatives | $ | 159,686 | | $ | 170,851 | | $ | (1,481 | ) | $ | (1,548 | ) | $ | 1,600 | | $ | 1,923 | | $ | (3,081 | ) | $ | (3,471 | ) | | | | | | | |
| | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The derivative instruments related to this strategy are held for other investment purposes. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | These derivatives are embedded within liabilities and are not held for risk management purposes. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Change in Notional Amount |
The net decrease in notional amount of derivatives since December 31, 2013 was primarily due to the following: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The decrease in notional amount related to the U.S. GMWB hedging instruments and the U.S. macro hedge program was primarily driven by the expiration of certain out-of-the-money options. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The decrease in notional amount related to the international program hedging instruments resulted from a reduction in the liability position due to continued elevated surrender and withdrawal rates as well as portfolio re-balancing including the termination of offsetting positions and the expiration of certain out-of-the-money options. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The decrease in notional amount related to credit derivatives in offsetting positions and interest rate swaps was primarily related to maturities. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Change in Fair Value |
The net increase in the total fair value of derivative instruments since December 31, 2013 was primarily related to the following: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The fair value associated with the international program hedging instruments increased primarily from re-balancing of the portfolio, partially offset by a decrease in volatility and interest rates. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The fair value related to the combined U.S. GMWB hedging program, which includes the GMWB product, reinsurance, and hedging derivatives, was primarily driven by outperformance of underlying actively managed funds compared to their respective indices. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The coinsurance and modified coinsurance reinsurance contracts represent U.S. and International product guarantees that are ceded to an affiliate. The primary driver of the decline in the fair value of these derivatives is a result of changes in the unrealized gains/losses of the underlying portfolios associated with these contracts. For a discussion related to the reinsurance agreement refer to Note 11 - Transactions with Affiliates and Note 2 - Business Dispositions of Notes to Condensed Consolidated Financial Statements for more information on this transaction. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Offsetting of Derivative Assets/Liabilities |
The following tables present the gross fair value amounts, the amounts offset, and net position of derivative instruments eligible for offset in the Company's Condensed Consolidated Balance Sheets. Amounts offset include fair value amounts, income accruals and related cash collateral receivables and payables associated with derivative instruments that are traded under a common master netting agreement, as described above. Also included in the tables are financial collateral receivables and payables, which are contractually permitted to be offset upon an event of default, although are disallowed for offsetting under U.S. GAAP. |
As of March 31, 2014 |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (i) | | (ii) | | (iii) =i) - (ii) | (iv) | | (v) =iii) - (iv) | | | | | | | | |
| | | | | Net Amounts Presented in the Statement of Financial Position | | Collateral Disallowed for Offset in the Statement of Financial Position | | | | | | | | | | |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Assets [1] | | Accrued Interest and Cash Collateral Received [2] | | Financial Collateral Received [4] | | Net Amount | | | | | | | | |
Description | | | | | | | | | | | | | | | | | | | |
Other investments | $ | 1,288 | | | $ | 1,112 | | | $ | 169 | | | $ | 7 | | | $ | 124 | | | $ | 52 | | | | | | | | | |
| | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Liabilities [3] | | Accrued Interest and Cash Collateral Pledged [3] | | Financial Collateral Pledged [4] | | Net Amount | | | | | | | | |
Description | | | | | | | | | | | | | | | | | | | |
Other liabilities | $ | (1,682 | ) | | $ | (973 | ) | | $ | (563 | ) | | $ | (146 | ) | | $ | (739 | ) | | $ | 30 | | | | | | | | | |
| | | | | | | |
|
|
|
As of December 31, 2013 |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| (i) | | (ii) | | (iii) =i) - (ii) | (iv) | | (v) =iii) - (iv) | | | | | | | | |
| | | | | Net Amounts Presented in the Statement of Financial Position | | Gross Amounts Not Offset in the Statement of Financial Position | | | | | | | | | | |
| Gross Amounts of Recognized Assets | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Assets [1] | | Accrued Interest and Cash Collateral Received [2] | | Financial Collateral Received [4] | | Net Amount | | | | | | | | |
Description | | | | | | | | | | | | | | | | | | | |
Other investments | $ | 1,510 | | | $ | 1,290 | | | $ | 272 | | | $ | (52 | ) | | $ | 121 | | | $ | 99 | | | | | | | | | |
| | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Gross Amounts of Recognized Liabilities | | Gross Amounts Offset in the Statement of Financial Position | | Derivative Liabilities [3] | | Accrued Interest and Cash Collateral Pledged [3] | | Financial Collateral Pledged [4] | | Net Amount | | | | | | | | |
Description | | | | | | | | | | | | | | | | | | | |
Other liabilities | $ | (2,063 | ) | | $ | (1,308 | ) | | $ | (825 | ) | | $ | 70 | | | $ | (826 | ) | | $ | 71 | | | | | | | | | |
| | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | Included in other invested assets in the Company's Condensed Consolidated Balance Sheets. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | Included in other assets in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative receivable associated with each counterparty. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[3] | Included in other liabilities in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative payable associated with each counterparty. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[4] | Excludes collateral associated with exchange-traded derivative instruments. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Cash Flow Hedges |
For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is reported as a component of OCI and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing hedge ineffectiveness are recognized in current period earnings. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness. |
The following tables present the components of the gain or loss on derivatives that qualify as cash flow hedges: |
Derivatives in Cash Flow Hedging Relationships |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Gain (Loss) Recognized in OCI on Derivative (Effective Portion) | | Net Realized Capital Gains(Losses) Recognized in Income on Derivative (Ineffective Portion) | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | Three months ended March 31, | | | | | | | | | | | | | | | | | | |
| 2014 | 2013 | | 2014 | 2013 | | | | | | | | | | | | | | | | | | |
Interest rate swaps | $ | 10 | | $ | (42 | ) | | $ | (1 | ) | $ | — | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Foreign currency swaps | (1 | ) | 1 | | | — | | — | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Total | $ | 9 | | $ | (41 | ) | | $ | (1 | ) | $ | — | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Gain or (Loss) Reclassified from AOCI into Income (Effective Portion) | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three months ended March 31, | | | | | | | | | | | | | | | | | | | | | | | | |
| Location | 2014 | 2013 | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate swaps | Net realized capital gain/(loss) | $ | 1 | | $ | 64 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Interest rate swaps | Net investment income | 13 | | 14 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Foreign currency swaps | Net realized capital gain/(loss) | — | | (3 | ) | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
Total | | $ | 14 | | $ | 75 | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | |
As of March 31, 2014 the before-tax deferred net gains on derivative instruments recorded in AOCI that are expected to be reclassified to earnings during the next twelve months are $43. This expectation is based on the anticipated interest payments on hedged investments in fixed maturity securities that will occur over the next twelve months, at which time the Company will recognize the deferred net gains (losses) as an adjustment to interest income over the term of the investment cash flows. |
During the three months ended March 31, 2014 and March 31, 2013 the Company had no net reclassifications from AOCI to earnings resulting from the discontinuance of cash-flow hedges due to forecasted transactions that were no longer probable of occurring. |
Fair Value Hedges |
For derivative instruments that are designated and qualify as a fair value hedge, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. The Company includes the gain or loss on the derivative in the same line item as the offsetting loss or gain on the hedged item. All components of each derivative’s gain or loss were included in the assessment of hedge effectiveness. |
The Company recognized in income gains (losses) representing the ineffective portion of fair value hedges as follows: |
Derivatives in Fair-Value Hedging Relationships |
| | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Gain or (Loss) Recognized in Income [1] | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | | | | | | | | | | | | | | | | | |
| 2014 | | 2013 | | | | | | | | | | | | | | | | | | |
| Derivative | Hedge Item | | Derivative | Hedge Item | | | | | | | | | | | | | | | | | | |
Interest rate swaps | | | | | | | | | | | | | | | | | | | | | | | |
Net realized capital gain/(loss) | $ | (1 | ) | $ | 2 | | | $ | 6 | | $ | (8 | ) | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Foreign currency swaps | | | | | | | | | | | | | | | | | | | | | | | |
Net realized capital gain/(loss) | | | | | | (2 | ) | 2 | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Benefits, losses and loss adjustment expenses | — | | | | | (1 | ) | 1 | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Total | $ | (1 | ) | $ | 2 | | | $ | 3 | | $ | (5 | ) | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The amounts presented do not include the periodic net coupon settlements of the derivative or the coupon income (expense) related to the hedged item. The net of the amounts presented represents the ineffective portion of the hedge. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Non-qualifying Strategies |
For non-qualifying strategies, including embedded derivatives that are required to be bifurcated from their host contracts and accounted for as derivatives, the gain or loss on the derivative is recognized currently in earnings within net realized capital gains (losses). The following table presents the gain or loss recognized in income on non-qualifying strategies: |
Derivatives Used in Non-Qualifying Strategies |
Gain or (Loss) Recognized within Net Realized Capital Gains and Losses |
| | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three months ended March 31, | | | | | | | | | | | | | | | | | | | | | | | | | |
| 2014 | 2013 | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Interest rate swaps, caps, floors, and forwards | $ | 1 | | $ | 10 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Foreign exchange contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Foreign currency swaps and forwards | 1 | | — | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Japan 3Win foreign currency swaps [1] | 15 | | (130 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Japanese fixed annuity hedging instruments [2] | 12 | | (101 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Credit contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Credit derivatives that purchase credit protection | (3 | ) | (5 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Credit derivatives that assume credit risk | — | | 9 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Equity contracts | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Equity index swaps and options | — | | (14 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Variable annuity hedge program | | | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. GMWB product derivatives | 36 | | 456 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
U.S. GMWB reinsurance contracts | (4 | ) | (60 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. GMWB hedging instruments | (17 | ) | (349 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
U.S. macro hedge program | (10 | ) | (85 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
International program hedging instruments | (23 | ) | (83 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Other | | | | | | | | | | | | | | | | | | | | | | | | | | | |
GMAB, GMWB, and GMIB reinsurance contracts | 51 | | 337 | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | |
Coinsurance and modified coinsurance reinsurance contracts | (130 | ) | (396 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
Total [3] | $ | (71 | ) | $ | (411 | ) | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The associated liability is adjusted for changes in spot rates through realized capital gains and was $(28) and $116 for the three months ended March 31, 2014 and 2013, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | The associated liability is adjusted for changes in spot rates through realized capital gains and was $(30) and $151 for the three months ended March 31, 2014 and 2013, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[3] | Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 3 - Fair Value Measurements. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
For the three months ended March 31, 2014 the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily comprised of the following: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net loss on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument largely offsets the net gain on the GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement, refer to Note 13 - Transactions with Affiliates of the notes to the Condensed Consolidated Financial Statements for more information on this transaction. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net losses associated with the international program hedging instruments were primarily driven by a decrease in volatility and interest rates. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net gain on derivatives associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to a decline in volatility and policyholder experience. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net gain related to the combined U.S. GMWB hedging program, which includes the U.S. GMWB product, reinsurance, and hedging derivatives, was primarily due to outperformance of underlying actively managed funds compared to their respective indices. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
In addition, for the three months ended March 31, 2014, the Company received gains of $7 on derivative instruments as a result of prior counterparty losses related to the bankruptcy of Lehman Brothers Inc. The losses were the result of the contractual collateral threshold amounts and open collateral calls prior to the bankruptcy filing as well as interest rate and credit spread movements from the date of the last collateral call to the date of the bankruptcy filing. |
For the three months ended March 31, 2013 the net realized capital gain (loss) related to derivatives used in non-qualifying strategies was primarily comprised of the following: |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net loss associated with the international program hedging instruments was primarily driven by an improvement in global equity markets and depreciation of the Japanese yen in relation to the euro and the U.S. dollar. These losses were partially offset by gains due to a decrease in Japanese interest rates. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net gain on derivatives associated with GMAB, GMWB, and GMIB reinsurance contracts, which are reinsured to an affiliated captive reinsurer, was primarily due to an improvement in global and domestic equity markets and a decrease in currency volatility. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net loss on the coinsurance and modified coinsurance reinsurance agreement, which is accounted for as a derivative instrument, primarily offsets the net gain on GMAB, GMWB, and GMIB reinsurance contracts. For a discussion related to the reinsurance agreement refer to Note 11 - Transactions with Affiliates for more information on this transaction. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net loss related to the Japanese fixed annuity hedging instruments and the Japan 3Win foreign currency swaps was primarily due to depreciation of the Japanese yen in relation to the U.S. dollar. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net gain related to the combined U.S. GMWB hedging program, which includes the U.S. GMWB product, reinsurance, and hedging derivatives, was primarily a result of favorable policyholder behavior. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
• | The net loss on U.S. macro hedge program was primarily due to an improvement in domestic equity markets, the passage of time, and lower equity volatility. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
For additional disclosures regarding contingent credit related features in derivative agreements, see Note 7 - Separate Accounts, Death Benefits and Other Insurance Benefit Features of Notes to Condensed Consolidated Financial Statements. |
Credit Risk Assumed through Credit Derivatives |
The Company enters into credit default swaps that assume credit risk of a single entity or referenced index in order to synthetically replicate investment transactions. The Company will receive periodic payments based on an agreed upon rate and notional amount and will only make a payment if there is a credit event. A credit event payment will typically be equal to the notional value of the swap contract less the value of the referenced security issuer’s debt obligation after the occurrence of the credit event. A credit event is generally defined as a default on contractually obligated interest or principal payments or bankruptcy of the referenced entity. The credit default swaps in which the Company assumes credit risk primarily reference investment grade single corporate issuers and baskets, which include standard and customized diversified portfolios of corporate issuers. The diversified portfolios of corporate issuers are established within sector concentration limits and may be divided into tranches that possess different credit ratings. |
The following tables present the notional amount, fair value, weighted average years to maturity, underlying referenced credit obligation type and average credit ratings, and offsetting notional amounts and fair value for credit derivatives in which the Company is assuming credit risk as of March 31, 2014 and December 31, 2013. |
As of March 31, 2014 |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Underlying Referenced | | | | | | | | | | | | | | | | | | |
Credit Obligation(s) [1] | | | | | | | | | | | | | | | | |
Credit Derivative type by derivative | Notional | Fair | Weighted | Type | Average | Offsetting | Offsetting | | | | | | | | | | | | | | | | |
risk exposure | Amount [2] | Value | Average | Credit | Notional | Fair Value [3] | | | | | | | | | | | | | | | | |
| | | Years to | Rating | Amount [3] | | | | | | | | | | | | | | | | | |
| | | Maturity | | | | | | | | | | | | | | | | | | | |
Single name credit default swaps | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | $ | 297 | | $ | 5 | | 4 years | Corporate Credit/ | A- | $ | 163 | | $ | (3 | ) | | | | | | | | | | | | | | | | |
Foreign Gov. | | | | | | | | | | | | | | | | |
Below investment grade risk exposure | 24 | | — | | 4 months | Corporate Credit | CCC | 24 | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Basket credit default swaps [4] | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | 1,881 | | 22 | | 3 years | Corporate Credit | BBB+ | 857 | | (10 | ) | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Below investment grade risk exposure | 42 | | 3 | | 5 years | Corporate Credit | B | — | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Investment grade risk exposure | 240 | | (4 | ) | 3 years | CMBS Credit | AA- | 234 | | 4 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Below investment grade risk exposure | 115 | | (16 | ) | 3 years | CMBS Credit | B | 115 | | 15 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Embedded credit derivatives | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | 150 | | 145 | | 3 years | Corporate Credit | A- | — | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Total [5] | $ | 2,749 | | $ | 155 | | | | | $ | 1,393 | | $ | 6 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
As of December 31, 2013 |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | Underlying Referenced | | | | | | | | | | | | | | | | | | |
Credit Obligation(s) [1] | | | | | | | | | | | | | | | | |
Credit Derivative type by derivative | Notional | Fair | Weighted | Type | Average | Offsetting | Offsetting | | | | | | | | | | | | | | | | |
risk exposure | Amount [2] | Value | Average | Credit | Notional | Fair Value [3] | | | | | | | | | | | | | | | | |
| | | Years to | Rating | Amount [3] | | | | | | | | | | | | | | | | | |
| | | Maturity | | | | | | | | | | | | | | | | | | | |
Single name credit default swaps | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | $ | 735 | | $ | 6 | | 2 years | Corporate Credit/ Foreign Gov. | A | $ | 592 | | $ | (4 | ) | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Below investment grade risk exposure | 24 | | — | | 1 year | Corporate Credit | CCC | 25 | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Basket credit default swaps [4] | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | 1,912 | | 25 | | 3 years | Corporate Credit | BBB+ | 784 | | (10 | ) | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Below investment grade risk exposure | 87 | | 8 | | 5 years | Corporate Credit | BB- | — | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Investment grade risk exposure | 235 | | (5 | ) | 3 years | CMBS Credit | A | 235 | | 5 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Below investment grade risk exposure | 115 | | (18 | ) | 3 years | CMBS Credit | B- | 115 | | 18 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Embedded credit derivatives | | | | | | | | | | | | | | | | | | | | | | | |
Investment grade risk exposure | 150 | | 145 | | 3 years | Corporate Credit | BBB+ | — | | — | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Total [5] | $ | 3,258 | | $ | 161 | | | | | $ | 1,751 | | $ | 9 | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[1] | The average credit ratings are based on availability and the midpoint of the applicable ratings among Moody’s, S&P, Fitch, and Morningstar. If no rating is available from a rating agency, then an internally developed rating is used. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[2] | Notional amount is equal to the maximum potential future loss amount. These derivatives are governed by agreements and clearing house rules and applicable law which include collateral posting requirements. There is no additional specific collateral related to these contracts or recourse provisions included in the contracts to offset losses going forward. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[3] | The Company has entered into offsetting credit default swaps to terminate certain existing credit default swaps, thereby offsetting the future changes in value of, or losses paid related to, the original swap. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[4] | Includes $2.3 billion and $2.3 billion as of March 31, 2014 and December 31, 2013, respectively, of standard market indices of diversified portfolios of corporate issuers referenced through credit default swaps. These swaps are subsequently valued based upon the observable standard market index. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
[5] | Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 3 - Fair Value Measurements. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Derivative Collateral Arrangements |
The Company enters into various collateral arrangements in connection with its derivative instruments, which require both the pledging and accepting of collateral. As of March 31, 2014 and December 31, 2013 the Company pledged securities collateral associated with derivative instruments with a fair value of $763 and $865, respectively, which have been included in fixed maturities on the Condensed Consolidated Balance Sheets. The counterparties have the right to sell or re-pledge these securities. The Company also pledged cash collateral associated with derivative instruments with a fair value of $58 and $290, respectively, as of March 31, 2014 and December 31, 2013 which have been primarily included within other assets on the Company's Condensed Consolidated Balance Sheets. |
As of March 31, 2014 and December 31, 2013 the Company accepted cash collateral associated with derivative instruments with a fair value of $225 and $171, respectively, which was invested and recorded in the Company's Condensed Consolidated Balance Sheets in fixed maturities and short-term investments with corresponding amounts recorded in other liabilities. The Company also accepted securities collateral as of March 31, 2014 and December 31, 2013 of $124 and $121, respectively, of which the Company has the ability to sell or repledge $124 and $117, respectively. As of March 31, 2014 and December 31, 2013 the fair value of repledged securities totaled $0 and $39, respectively, and the Company did not sell any securities. In addition, as of March 31, 2014 and December 31, 2013 non-cash collateral accepted was held in separate custodial accounts and was not included in the Company’s Condensed Consolidated Balance Sheets. |